Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UVA TESTING METHODOLOGY: IN VIVO/IN VITRO COMBINATION METHOD SUGGESTED

This article was originally published in The Tan Sheet

Executive Summary

UVA TESTING METHODOLOGY: IN VIVO/IN VITRO COMBINATION METHOD SUGGESTED by Nicholas Lowe, MD, UCLA School of Medicine, as a testing standard to predict the protective effect of LIVA sunscreens. Speaking at a May 12 public workshop sponsored by FDA on UVA testing methods, Lowe advised FDA to "decide on an appropriate in vivo test which will give us performance data in humans [and] will tell us the characteristics of a specific formulation." He recommended that the in vivo test be used in combination with an in vitro test which will supply "accurate spectral absorbance data."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082801

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel